Illness	Number of cases
Hyperplasia of prostate (N40)	182
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1)	156
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5)	145
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	128
Malignant neoplasm of prostate (C61)	112
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	109
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	83
Obstructive and reflux uropathy - Hydronephrosis with ureteropelvic junction obstruction (N13.0)	60
Calculus of kidney and ureter - Calculus of ureter (N20.1)	47
Calculus of kidney and ureter - Calculus of kidney (N20.0)	38

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	937
Insertion, exchange or removal of a ureteral stent (8-137.10)	435
(9-984.7)	220
Insertion, exchange or removal of a ureteral stent (8-137.00)	182
(9-984.8)	169
Surgical creation of a connection between the urinary bladder and skin of the abdomen for artificial urinary drainage (5-572.1)	151
Exchange or removal of a urinary catheter through the abdominal wall (8-133.0)	126
(9-984.9)	114
Examination of the ureter by endoscopy (1-665)	113
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	101

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Nein

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ07

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
73	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
22	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
8	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Doctoral supervision
Participation in multi-centre phase III/IV studies
Student training (clinical traineeship / internship year)